PRA’s bioanalytical laboratories offer a wide range of specialized and complex services, for pre-clinical and Phase I-IV trials.
PRA Health Sciences delivers innovative drug development solutions that improve patients’ lives. Our people work tirelessly for clients, offering exceptional experience across all phases, therapeutic areas and a broad spectrum of services. With 14,000+ employees covering 85+ countries, we provide an impressive global presence and in-depth knowledge of local regulations, standards of care and cultural customs. At PRA, we love what do, because we are making a difference in the lives of patients and their family members worldwide. PRA operates 2 bioanalytical laboratories: 1 in Europe (the Netherlands) and 1 in North America (Lenexa, Kansas). Both offer specialized and complex services, including small and large molecule analysis for pre-clinical and Phase I-IV trials, flow cytometry, analysis of radioisotope compounds and biohazardous samples, immunogenicity testing, biomarkers, and FACS analysis.